ShockWave Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	13	11	11	-	-
Operating Expenses	13	11	11	-	-
Operating Income	-13	-11	-11	-	-
Interest Expense	-29	-29	-10	-8	-15
Earnings From Equity Investments	263	238	22	72	-206
Other Non Operating Income (Expenses)	-191	-239	-181	419	-389
EBT Excluding Unusual Items	30	-41	-180	483	-610
Gain (Loss) on Sale of Investments	-	-	-	-	152
Pretax Income	30	-41	-180	483	-458
Income Tax Expense	7	-8	-38	101	-100
Earnings From Continuing Operations	23	-33	-142	382	-358
Earnings From Discontinued Operations	-	-	-	1,120	-
Net Income to Company	23	-33	-142	1,502	-358
Minority Interest in Earnings	2	2	-	-210	-
Net Income	25	-31	-142	1,292	-358
Net Income to Common	25	-31	-142	1,292	-358
Shares Outstanding (Basic)	92	92	-	-	-
Shares Outstanding (Diluted)	92	92	-	-	-
EPS (Basic)	0.27	-0.34	-	-	-
EPS (Diluted)	0.27	-0.34	-	-	-
EBIT	-13	-11	-11	-	-
Effective Tax Rate	23.33%	-	-	20.91%	-
Advertising Expenses	-	-	-	-	6.2

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q